Research Roundup

innovation: candle, tungsten bulb, two modern light bulbs
Debbie Rigby takes a look at the latest in research news Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes Evaluation Of patients in the ORBIT-AF II trial shows 541 NOAC-treated patients (9.4%) were underdosed, 197 were overdosed (3.4%), and 5,000 were dosed according to U.S. labeling (87%). NOAC overdosing was associated with

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Immaturity being diagnosed as ADHD?
Next Forum: DD-Book